Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Novartis AG ADS (NY: NVS)
73.82 USD  -0.80 (-1.07%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Novartis AG ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Most active stock of Healthcare sector: PFE, JNJ, ABT, NVS, MRK Reports Pennystockexchange.net
April 20, 2011
from EmailWire.Com Press Releases
Stocks In Focus: JNJ, GS, PCAR, STLD, NVS, APP, BMI, BK, BIO, BBBB, BRO, CHS, CR, ETN Reports OtcStockriot.com
April 19, 2011
from EmailWire.Com Press Releases
The Zacks Analyst Blog Highlights: Alcon, Novartis AG, Lazard, Celgene and Elan
April 11, 2011
from PR Newswire
StockMister.com Reports on NYSE Popular Volume actives: C, BAC, S, F, GE, PFE, GLW, NVS, AA and T
April 11, 2011
from EmailWire.Com Press Releases
ITG's Majestic Market Research Prostate Cancer Study Indicates Amgen's Xgeva is Poised to Steal Significant Share From Novartis' Zometa; Physicians Still on the Fence About Dendreon's Provenge
March 22, 2011
from PR Newswire
Pharma Diagnosis for 2011: Increased Project Spending, Decreased Staff, a "Navigating the Currents of Change" Webcast on Industrialinfo.com
March 16, 2011
from Marketwired News Releases
BestOfOTC.com Stocks to Watch at NYSE: (BRK.A, C, NVS, BAC, KV.A, EEM, ETN, F)
March 03, 2011
from EmailWire.Com Press Releases
BestOfOTC.com Noticeable Movements at NYSE: (HHC, KV.A, MIM, GG, HDB, MXT, NVS, C)
March 03, 2011
from EmailWire.Com Press Releases
Zacks Analyst Blog Highlights: Biogen Idec, Elan Corp, Novartis, Roche and Teva
February 02, 2011
from PR Newswire
The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Genoptix, Inc. in Connection with the Sale of the Company to Novartis AG - GXDX
February 01, 2011
from Business Wire News Releases
(NASDAQ: KERX) Rated a "BUY" by 5 Wall Street Firms
January 27, 2011
Note to Editors: The Following Is an Investment Opinion Being Issued by the IO News Wire Read More
from Marketwired News Releases
The Law Office of Joseph Klein is Investigating Possible Breaches of Fiduciary Duty by the Board of Genoptix, Inc. in Connection with the Sale of the Company to Novartis - GXDX
January 26, 2011
from Business Wire News Releases
Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Genoptix, Inc. - GXDX
January 26, 2011
from Business Wire News Releases
The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Genoptix, Inc. in Connection with the Sale of the Company to Novartis AG - GXDX
January 25, 2011
from Business Wire News Releases
Law Office of Brodsky & Smith, LLC Announces Investigation of Genoptix, Inc.
January 24, 2011
from Business Wire News Releases
The Law Firm of Weiss & Lurie Investigates the Acquisition of Genoptix, Inc.
January 24, 2011
from Business Wire News Releases
The Law Office of Robbins Umeda LLP Announces an Investigation of the Acquisition of Genoptix, Inc. by Novartis AG
January 24, 2011
from Business Wire News Releases
(NASDAQ: KERX) Under The Radar
January 24, 2011
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO News Wire. Read More
from Marketwired News Releases
From Cannabis to Catheters, Pharma-Biotech Industry Closes Out 2010 With 85 New Facilities and $7.1 Billion Potential Investment, an Industrial Info News Alert
December 20, 2010
from Marketwired News Releases
Most Highly Traded Stocks Today (C, RF, BAC, NVS) by EquityMarketReport.com
December 15, 2010
from EmailWire.Com Press Releases
Equity Research on Novartis AG and GlaxoSmithKline plc - Big Pharma Facing Lawsuits and Increased Regulatory Scrutiny
November 22, 2010
from Marketwired News Releases
(OTC: SPPH) Ready to Take a Piece of $18 Billion Market
October 29, 2010
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO News Wire Read More
from Marketwired News Releases
Phase III data show that Novartis meningococcal vaccine Menveo(R) demonstrated robust immunogenicity in infants
October 25, 2010
from Marketwired News Releases
BestOfOTC.com Highly traded stocks of the day: (LEG, WIT, LFC, CHA, NVS, AAPL)
October 25, 2010
from EmailWire.Com Press Releases
Novartis Phase III study indicates MF59(R) adjuvanted influenza vaccine, Fluad(R), is 75 percent more efficacious than studied non-adjuvanted vaccines in young children
October 22, 2010
from Marketwired News Releases
Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating Hormonal Disorder
September 22, 2010
SOM230 reduced urinary free cortisol (UFC) levels in majority of patients; 26% of patients randomized to SOM230 900ug achieved normal UFC levels Read More
from PR Newswire
Critical Alerts for Wal-Mart, Comcast, Gap, Novartis, and Crocs Released by Seven Summits Research
September 15, 2010
from PR Newswire
GenVec Achieves First Milestone in Collaboration
September 14, 2010
from PR Newswire
Novartis completa la compra a Nestlé de intereses mayoritarios en Alcon
August 26, 2010
from Business Wire Spanish
Novartis Completes Purchase from Nestlé of Majority Interest in Alcon
August 26, 2010
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here